Clinical Trial Update: Role of Positron Emission Mammography (PEM) Flex Solo II Positron Emission Tomography (PET) Scanner in Evaluating Neoadjuvant Chemotherapy Response in Patients With Breast Cancer [NA]

View source ↗

Summary

A terminated clinical trial evaluating the role of PEM (PEM Flex Solo II) PET imaging in assessing neoadjuvant chemotherapy response in breast cancer. Results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Chicago | Conditions: Breast Cancer | NA | Status: TERMINATED | Results posted: 2015-07-27